Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: ONCOGENE PROTEINS, FUSION - GENETICS , . Treffer: 22
2022
Brcic, I; Scheipl, S; Bergovec, M; Leithner, A; Szkandera, J; Sotlar, K; Suda, A; Smolle, MA; Kraus, T; Rosenberg, AE; Liegl-Atzwanger, B; Igrec, J
Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging EWSR1/FUS::NFATC2 Neoplasms of the Bone and Soft Tissue.
Int J Mol Sci. 2022; 23(24):
Doi: 10.3390/ijms232416196
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Igrec, J; Brčić, I; Igrec, R; Bergovec, M; Kashofer, K; Fuchsjäger, M; Leithner, A; Liegl-Atzwanger, B
Intraarticular Nodular Fasciitis of the Knee With MHY9-USP6 Fusion: A Case Report.
Int J Surg Pathol. 2020; 28(6):672-677
Doi: 10.1177/1066896920908054
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Schwaab, J; Naumann, N; Luebke, J; Jawhar, M; Somervaille, TCP; Williams, MS; Frewin, R; Jost, PJ; Lichtenegger, FS; La Rosée, P; Storch, N; Haferlach, T; Horny, HP; Fabarius, A; Haferlach, C; Burchert, A; Hofmann, WK; Cross, NCP; Hochhaus, A; Reiter, A; Metzgeroth, G
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
Am J Hematol. 2020; 95(7):824-833
Doi: 10.1002/ajh.25825
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Byrgazov, K; Kastner, R; Gorna, M; Hoermann, G; Koenig, M; Lucini, CB; Ulreich, R; Benesch, M; Strenger, V; Lackner, H; Schwinger, W; Sovinz, P; Haas, OA; van den Heuvel-Eibrink, M; Niemeyer, CM; Hantschel, O; Valent, P; Superti-Furga, G; Urban, C; Dworzak, MN; Lion, T
NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors.
Leukemia. 2017; 31(1):237-240
Doi: 10.1038/leu.2016.250
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Richtig, G; Hoeller, C; Kashofer, K; Aigelsreiter, A; Heinemann, A; Kwong, LN; Pichler, M; Richtig, E
Beyond the BRAFV600E hotspot: biology and clinical implications of rare BRAF gene mutations in melanoma patients.
Br J Dermatol. 2017; 177(4):936-944
Doi: 10.1111/bjd.15436
Web of Science
PubMed
FullText
FullText_MUG
Sheffield, NC; Pierron, G; Klughammer, J; Datlinger, P; Schönegger, A; Schuster, M; Hadler, J; Surdez, D; Guillemot, D; Lapouble, E; Freneaux, P; Champigneulle, J; Bouvier, R; Walder, D; Ambros, IM; Hutter, C; Sorz, E; Amaral, AT; de Álava, E; Schallmoser, K; Strunk, D; Rinner, B; Liegl-Atzwanger, B; Huppertz, B; Leithner, A; de Pinieux, G; Terrier, P; Laurence, V; Michon, J; Ladenstein, R; Holter, W; Windhager, R; Dirksen, U; Ambros, PF; Delattre, O; Kovar, H; Bock, C; Tomazou, EM
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.
Nat Med. 2017; 23(3):386-395
Doi: 10.1038/nm.4273
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Dutta, S; Krause, A; Vosberg, S; Herold, T; Ksienzyk, B; Quintanilla-Martinez, L; Tizazu, B; Chopra, M; Graf, A; Krebs, S; Blum, H; Greif, PA; Vetter, A; Metzeler, K; Rothenberg-Thurley, M; Schneider, MR; Dahlhoff, M; Spiekermann, K; Zimber-Strobl, U; Wolf, E; Bohlander, SK
The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models.
Leukemia. 2016; 30(5): 1166-1176.
Doi: 10.1038/leu.2015.349
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hartmann, L; Dutta, S; Opatz, S; Vosberg, S; Reiter, K; Leubolt, G; Metzeler, KH; Herold, T; Bamopoulos, SA; Bräundl, K; Zellmeier, E; Ksienzyk, B; Konstandin, NP; Schneider, S; Hopfner, KP; Graf, A; Krebs, S; Blum, H; Middeke, JM; Stölzel, F; Thiede, C; Wolf, S; Bohlander, SK; Preiss, C; Chen-Wichmann, L; Wichmann, C; Sauerland, MC; Büchner, T; Berdel, WE; Wörmann, BJ; Braess, J; Hiddemann, W; Spiekermann, K; Greif, PA
ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.
Nat Commun. 2016; 7(1): 11733-11733.
Doi: 10.1038/ncomms11733
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Ugurel, S; Mentzel, T; Utikal, J; Helmbold, P; Mohr, P; Pföhler, C; Schiller, M; Hauschild, A; Hein, R; Kämpgen, E; Kellner, I; Leverkus, M; Becker, JC; Ströbel, P; Schadendorf, D
Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up.
Clin Cancer Res. 2014; 20(2):499-510
Doi: 10.1158/1078-0432.CCR-13-1411
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Opatz, S; Polzer, H; Herold, T; Konstandin, NP; Ksienzyk, B; Zellmeier, E; Vosberg, S; Graf, A; Krebs, S; Blum, H; Hopfner, KP; Kakadia, PM; Schneider, S; Dufour, A; Braess, J; Sauerland, MC; Berdel, WE; Büchner, T; Woermann, BJ; Hiddemann, W; Spiekermann, K; Bohlander, SK; Greif, PA
Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia.
Blood. 2013; 122(10): 1761-1769.
Doi: 10.1182/blood-2013-01-476473
Web of Science
PubMed
FullText
FullText_MUG
2011
Ban, J; Jug, G; Mestdagh, P; Schwentner, R; Kauer, M; Aryee, DN; Schaefer, KL; Nakatani, F; Scotlandi, K; Reiter, M; Strunk, D; Speleman, F; Vandesompele, J; Kovar, H
Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma.
Oncogene. 2011; 30(18): 2173-2180.
Doi: 10.1038/onc.2010.581
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Lemez, P; Attarbaschi, A; Béné, MC; Bertrand, Y; Castoldi, G; Forestier, E; Garand, R; Haas, OA; Kagialis-Girard, S; Ludwig, WD; Matutes, E; Mejstríková, E; Pages, MP; Pickl, W; Porwit, A; Orfao, A; Schabath, R; Starı, J; Strobl, H; Talmant, P; van't Veer, MB; Zemanová, Z; European Group for the Immunological Characterization of Leukemias (EGIL)
Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases.
Eur J Haematol. 2010; 85(4):300-308
Doi: 10.1111/j.1600-0609.2010.01493.x
Web of Science
PubMed
FullText
FullText_MUG
2008
Bink, K; Haralambieva, E; Kremer, M; Ott, G; Beham-Schmid, C; de Leval, L; Peh, SC; Laeng, HR; Jütting, U; Hutzler, P; Quintanilla-Martinez, L; Fend, F
Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics.
Haematologica. 2008; 93(4): 623-626.
Doi: 10.3324/haematol.12005
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Strehl, S; Nebral, K; König, M; Harbott, J; Strobl, H; Ratei, R; Struski, S; Bielorai, B; Lessard, M; Zimmermann, M; Haas, OA; Izraeli, S
ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations.
Clin Cancer Res. 2008; 14(4):977-983
Doi: 10.1158/1078-0432.CCR-07-4022
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2006
Laczkó, I; Váró, G; Bottka, S; Bálint, Z; Illyés, E; Vass, E; Bertrand, JR; Malvy, C; Hollósi, M
N-terminal acylation of the SV40 nuclear localization signal peptide enhances its oligonucleotide binding and membrane translocation efficiencies.
Arch Biochem Biophys. 2006; 454(2):146-154
Doi: 10.1016/j.abb.2006.08.015
Web of Science
PubMed
FullText
FullText_MUG
Strehl, S; König, M; Meyer, C; Schneider, B; Harbott, J; Jäger, U; von Bergh, AR; Loncarevic, IF; Jarosova, M; Schmidt, HH; Moore, SD; Marschalek, R; Haas, OA
Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants.
Genes Chromosomes Cancer. 2006; 45(11):1041-1049
Doi: 10.1002/gcc.20372
Web of Science
PubMed
FullText
FullText_MUG
2005
Nebral, K; Schmidt, HH; Haas, OA; Strehl, S
NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15).
Clin Cancer Res. 2005; 11(18):6489-6494
Doi: 10.1158/1078-0432.CCR-05-0150
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schmidt, HH
MYST3/CREBBP (MOZ/CBP) and CREBBP/MYST3 (CBP/MOZ) transcripts in AML with t(8;16)(p11;p13).
Genes Chromosomes Cancer. 2005; 42(2):207-208
Doi: 10.1002/gcc.20112
Web of Science
PubMed
FullText
FullText_MUG
2002
Inoue, A; Seidel, MG; Wu, W; Kamizono, S; Ferrando, AA; Bronson, RT; Iwasaki, H; Akashi, K; Morimoto, A; Hitzler, JK; Pestina, TI; Jackson, CW; Tanaka, R; Chong, MJ; McKinnon, PJ; Inukai, T; Grosveld, GC; Look, AT
Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo.
Cancer Cell. 2002; 2(4):279-288
Doi: 10.1016/S1535-6108(02)00155-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2001
Laczika, K; Mitterbauer, G; Mitterbauer, M; Knöbl, P; Schwarzinger, I; Greinix, HT; Rabitsch, W; Fonatsch, C; Mannhalter, C; Lechner, K; Jaeger, U
Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions.
Leuk Lymphoma. 2001; 42(5):923-931
Doi: 10.3109/10428190109097711
Web of Science
PubMed
FullText
FullText_MUG
1999
Amann, G; Zoubek, A; Salzer-Kuntschik, M; Windhager, R; Kovar, H
Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family.
Hum Pathol. 1999; 30(9):1058-1064
Doi: 10.1016/S0046-8177(99)90223-X
Web of Science
PubMed
FullText
FullText_MUG
1993
Izraeli, S; Henn, T; Strobl, H; Ludwig, WD; Kovar, H; Haas, OA; Harbott, J; Bartram, CR; Gadner, H; Lion, T
Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
Leukemia. 1993; 7(12):2054-2056
Web of Science
PubMed
Google Scholar